Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

American business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Happy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

China's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...

India's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...

U.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 billion signed ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...

Chinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...

The US House earlier this year resoundingly voted in favor of the blacklist legislation, dubbed the Biosecure Act, and a bipartisan group i...

The US government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by Ch...

"Covaxin was developed against the original Wuhan variant," a Bharat Biotech spokesperson told Reuters in a text message, referring to the ...

The fertilizer issue has triggered farmer protests due to non-availability of chemical fertilizers. President Gotabaya Rajapaksa in May ord...

In a letter to the Bangladesh government on September 22, Beijing headquartered Sinovac Biotech said the phase 3 trials of the vaccine they...

The global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.

Consumers in Asia, especially India, China, Philippines are ready to accept the benefits of biotechnology derived foods, according to a con...